Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Capitol Capsule: Another stem cell win for Obama; but Romney, SCOTUS could undo

This article was originally published in Scrip

Executive Summary

After the US Court of Appeals for the District of Columbia on 24 August upheld federal funding for human embryonic stem cell (hESC) research and the Obama administration's rules for governing how taxpayer dollars are allocated and used for those activities, National Institutes of Health (NIH) Director Dr Francis Collins expressed confidence it was full speed ahead for the agency in funding and conducting the research.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC018567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel